Table 3.
Group | Sex | Dose (mg/kg/day) | Prothrombin Time (seconds) | Activated Partial Thromboplastin Time (seconds) | Fibrinogen (mg/dL) |
---|---|---|---|---|---|
1 | Male | 0 | 17.8 ± 1.2 | 18.4 ± 1.6 | 302 ± 27 |
2 | Male | 40 | 17.0 ± 0.8 | 17.3 ± 0.9 | 315 ± 22 |
3 | Male | 80 | 16.8 ± 0.7 | 19.1 ± 3.0 | 306 ± 28 |
4 | Male | 160 | 21.1 ± 2.0* | 40.5 ± 10.4* | 457 ± 56* |
1 | Female | 0 | 16.9 ± 0.5 | 15.1 ± 1.1 | 273 ± 35 |
2 | Female | 40 | 16.8 ± 0.8 | 15.1 ± 1.8 | 248 ± 22 |
3 | Female | 80 | 18.8 ± 1.4* | 23.9 ± 6.1* | 254 ± 84 |
4 | Female | 160 | 19.3 ± 1.2* | 34.2 ± 8.1* | 394 ± 33* |
p < 0.05 versus sex-matched vehicle controls